Status: Recruiting
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy.
Participants needed: 40
Trial details
Phase: Phase 3Age: 18+Biological sex: MaleType: InterventionalSponsor: Minoryx Therapeutics, S.L.Updated: Nov 17, 2025Locations: 13
Eligibility criteria
Subject is male and aged ≥18 years. [+5]
Subject who had previous bone marrow transplantation (HSCT) or treatment with ex... [+5]